Immunopathology of B-cell lymphomas induced in C57BL/6 mice by dualtropic murine leukemia virus (MuLV).
about
9-(2-Phosphonylmethoxyethyl)adenine in the treatment of murine acquired immunodeficiency disease and opportunistic herpes simplex virus infectionsAnalysis of the ex vivo and in vivo antiretroviral activity of gemcitabineCharacterization of the CD154-positive and CD40-positive cellular subsets required for pathogenesis in retrovirus-induced murine immunodeficiency.The CD154/CD40 interaction required for retrovirus-induced murine immunodeficiency syndrome is not mediated by upregulation of the CD80/CD86 costimulatory moleculesTetherin is a key effector of the antiretroviral activity of type I interferon in vitro and in vivo.Up-regulation of T helper 2 and down-regulation of T helper 1 cytokines during murine retrovirus-induced immunodeficiency syndrome enhances susceptibility of a resistant mouse strain to Leishmania amazonensis.Gain-of-function mutations of the p53 gene induce lymphohematopoietic metastatic potential and tissue invasiveness.Modulation of murine AIDS-related pathology by concurrent antibody treatment and coinfection with Leishmania majorImmunohistologic cellular phenotypes of lymphoproliferative disorders. Comprehensive evaluation of 564 cases including 257 non-Hodgkin's lymphomas classified by the International Working Formulation.Experimental models of lymphoproliferative disease. The mouse as a model for human non-Hodgkin's lymphomas and related leukemiasFunctional T lymphocytes are required for a murine retrovirus-induced immunodeficiency disease (MAIDS)The E mu-myc transgenic mouse. A model for high-incidence spontaneous lymphoma and leukemia of early B cellsCD4+ T cells are required for development of a murine retrovirus-induced immunodeficiency syndrome (MAIDS)Retroviral induction of acute lymphoproliferative disease and profound immunosuppression in adult C57BL/6 mice.The programmed death-1 and interleukin-10 pathways play a down-modulatory role in LP-BM5 retrovirus-induced murine immunodeficiency syndrome.Myeloid-derived suppressor cells in murine retrovirus-induced AIDS inhibit T- and B-cell responses in vitro that are used to define the immunodeficiencyAdoptive transfer of polyclonal and cloned cytolytic T lymphocytes (CTL) specific for mouse AIDS-associated tumors is effective in preserving CTL responses: a measure of protection against LP-BM5 retrovirus-induced immunodeficiency.Cytolytic T lymphocytes specific for tumors and infected cells from mice with a retrovirus-induced immunodeficiency syndrome.Retrovirus-induced murine acquired immunodeficiency syndrome: natural history of infection and differing susceptibility of inbred mouse strains.Abrogation of resistance to severe mousepox in C57BL/6 mice infected with LP-BM5 murine leukemia viruses.Opportunistic infections and retrovirus-induced immunodeficiency: studies of acute and chronic infections with Toxoplasma gondii in mice infected with LP-BM5 murine leukemia virusesAntibody to the ligand for CD40 (gp39) inhibits murine AIDS-associated splenomegaly, hypergammaglobulinemia, and immunodeficiency in disease-susceptible C57BL/6 mice.Ecotropic and mink cell focus-forming murine leukemia viruses integrate in mouse T, B, and non-T/non-B cell lymphoma DNA.CD40-associated TRAF 6 signaling is required for disease induction in a retrovirus-induced murine immunodeficiency.Mice transgenic for a soluble form of murine cytotoxic T lymphocyte antigen 4 are refractory to murine acquired immune deficiency sydrome development
P2860
Q28340432-B138CEB5-6DA8-4CE6-A223-E81AEFAD5D12Q28476738-0967A1E4-5BDF-40E6-9E58-6E086910A088Q33851104-1C99920E-FBA6-4016-BFC3-AF4D5EC04357Q34354116-A98921BF-6863-46F9-B0A5-5A89C809FE03Q35518677-E48EB5C1-7A38-4431-8CB4-1E747B6B7915Q35794840-69F088BF-1A07-4775-BCDA-40635A7CACBAQ35839280-A58633B4-A7E7-4D66-AA30-7F6CA8A8D16DQ35883083-40B62F49-90FF-488D-B61C-19482950FCF6Q35885948-FE5F966A-31E6-43B7-8D73-D47DCD3E5368Q35885953-EFAC1E4D-E7A7-4363-A2EF-78DAE3633E9CQ36352737-5FFDFEFF-303E-4395-A3D1-88F7084E51F1Q36354457-11E81040-EEB7-46F3-98FB-1D30C38F597FQ36355249-30D0A991-D6E0-4FDE-A6AB-860A88D57A60Q36355385-DD944EFF-D574-43FF-BDFE-6BE1673E619DQ36483852-48092264-A68D-42AF-9C5E-A7C9ED13D7FDQ36607445-D8C91464-AC10-41EB-9542-BAAA6177748AQ36623252-34F45B67-3DA0-4737-9FF6-19D0D79B570DQ36697749-391117E4-9005-4249-9EA2-D6D427B561F5Q36781641-62E0BBED-332C-44E0-B1FA-4BDF51FABD03Q36884500-311941C5-BD10-41BE-A4AA-531B7C946675Q36952760-9DFCA518-C330-4C06-BA44-5D533F77B593Q39874146-9645F6C5-F8C0-4BF4-BC50-64BEFF9D935FQ40125980-D647E7F8-D163-48D3-A2AF-0D661E5AEC30Q40883636-F90D453F-3BB0-470A-B806-0C75F061C1F7Q56906521-F2EB7973-89C8-4EFD-917F-50B78D23A928
P2860
Immunopathology of B-cell lymphomas induced in C57BL/6 mice by dualtropic murine leukemia virus (MuLV).
description
1982 nî lūn-bûn
@nan
1982年の論文
@ja
1982年学术文章
@wuu
1982年学术文章
@zh-cn
1982年学术文章
@zh-hans
1982年学术文章
@zh-my
1982年学术文章
@zh-sg
1982年學術文章
@yue
1982年學術文章
@zh
1982年學術文章
@zh-hant
name
Immunopathology of B-cell lymp ...... murine leukemia virus (MuLV).
@ast
Immunopathology of B-cell lymp ...... murine leukemia virus (MuLV).
@en
type
label
Immunopathology of B-cell lymp ...... murine leukemia virus (MuLV).
@ast
Immunopathology of B-cell lymp ...... murine leukemia virus (MuLV).
@en
prefLabel
Immunopathology of B-cell lymp ...... murine leukemia virus (MuLV).
@ast
Immunopathology of B-cell lymp ...... murine leukemia virus (MuLV).
@en
P2093
P2860
P1476
Immunopathology of B-cell lymp ...... c murine leukemia virus (MuLV)
@en
P2093
C R Taylor
J Jonasson
P K Pattengale
T Beardsley
P2860
P304
P407
P577
1982-06-01T00:00:00Z